1. Home
  2. KFRC vs EBS Comparison

KFRC vs EBS Comparison

Compare KFRC & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kforce Inc.

KFRC

Kforce Inc.

HOLD

Current Price

$29.58

Market Cap

470.6M

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$12.10

Market Cap

529.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFRC
EBS
Founded
1962
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.6M
529.9M
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
KFRC
EBS
Price
$29.58
$12.10
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$34.75
$15.00
AVG Volume (30 Days)
251.8K
867.1K
Earning Date
11-03-2025
10-29-2025
Dividend Yield
5.19%
N/A
EPS Growth
N/A
N/A
EPS
2.26
1.35
Revenue
$1,340,771,000.00
$788,900,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.42
P/E Ratio
$13.31
$8.92
Revenue Growth
N/A
N/A
52 Week Low
$24.49
$4.02
52 Week High
$61.81
$13.41

Technical Indicators

Market Signals
Indicator
KFRC
EBS
Relative Strength Index (RSI) 51.58 65.31
Support Level $29.00 $10.63
Resistance Level $30.42 $11.31
Average True Range (ATR) 1.06 0.59
MACD 0.03 0.13
Stochastic Oscillator 71.58 96.47

Price Performance

Historical Comparison
KFRC
EBS

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Share on Social Networks: